Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Cigna (0A77) Share Price & Analysis

1 Followers

0A77 Stock Chart & Stats

$301.48$6.70(2.27%)
At close: 4:30 PM GMT
$275$300Aug 10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2
Day’s Range
$293.00 - $304.71
52-Week Range
$250.00 - $320.96
Previous Close
$294.78
Volume
N/A
Average Volume (3M)
657
Market Cap
$78.07B
Enterprise Value
$104.94B
Total Cash (Recent Filing)
$6.30B
Total Debt (Recent Filing)
$31.88B
Price to Earnings (P/E)
12.6
Beta
0.39
Next Earnings
Feb 04, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
2.06%

Bulls Say, Bears Say

Bulls Say

Diversified Growth Platforms

Cigna combines insurance with pharmacy, specialty, behavioral health, and care-management services, creating multiple recurring revenue streams. Recent growth across both major platforms indicates broad demand and reduces reliance on a single product or customer segment over the coming quarters.

Strong Cash Generation

A large operating free-cash-flow base supports investment in technology, modernization, debt management, and shareholder returns without depending entirely on external financing. The close relationship between free cash flow and earnings also indicates meaningful cash conversion, supporting financial resilience.

Retention And Technology Advantage

Very high pharmacy-benefit retention supports recurring revenue and demonstrates customer stickiness. AI-enabled care coordination and measurable reductions in avoidable admissions can improve affordability and outcomes, strengthening Cigna’s service proposition and competitive position over time.

Bears Say

Medical Cost Pressure

Sustained high medical-cost inflation can compress insurance margins when claims rise faster than premiums or pricing resets. Although guidance was maintained, continued pressure raises the risk that elevated utilization and provider costs reduce earnings durability across future reporting periods.

PBS Transition Earnings Pressure

The transition to the rebate-free Signature model is requiring substantial investment and has already reduced Pharmacy Benefit Services earnings. Similar transition expenses are expected in 2027, creating a multi-period drag on margins before the intended operating benefits can emerge.

Meaningful Leverage

Leverage is manageable but still meaningful, which limits balance-sheet flexibility compared with stronger capital profiles. Debt obligations can constrain capital allocation and make it harder to absorb margin volatility or fund modernization if operating conditions weaken over the next several quarters.

Cigna News

0A77 FAQ

What was Cigna’s price range in the past 12 months?
Cigna lowest share price was $250.00 and its highest was $320.96 in the past 12 months.
What is Cigna’s market cap?
Cigna’s market cap is $78.07B.
When is Cigna’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cigna’s earnings last quarter?
Cigna released its earnings results on Nov 05, 2026. The company reported $5.47 earnings per share for the quarter, missing the consensus estimate of $7.521 by -$2.051.
Is Cigna overvalued?
According to Wall Street analysts Cigna’s price is currently Undervalued.
Does Cigna pay dividends?
Cigna does not currently pay dividends.
What is Cigna’s EPS estimate?
Cigna’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cigna have?
Cigna has 264,240,480 shares outstanding.
What happened to Cigna’s price movement after its last earnings report?
Cigna reported an EPS of $5.47 in its last earnings report, missing expectations of $7.521. Following the earnings report the stock price went down -1.91%.
Which hedge fund is a major shareholder of Cigna?
Hedge funds hold Cigna shares: the largest hedge-fund position in Cigna is 215,587,751 shares, and hedge funds increased their holdings by 1.8M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology